Bridging the Gap: Standardizing Alzheimer's Diagnostic Practices

Join our expert panel for a comprehensive discussion on the gaps and challenges in diagnosing Alzheimer's disease. We will examine the limitations of cognitive evaluation tools like MMSE and MoCA, and the impact of limited neuropsychological assessments on evaluating patients with mild cognitive impairment (MCI). The role of MRI protocols in identifying cerebral changes and the integration of blood-based biomarkers with CSF and PET imaging will also be discussed, focusing on improving diagnostic precision and early detection. Additionally, we will explore collaboration strategies among Southeast Asian countries to enhance the use of cognitive tools and neuropsychological assessments in memory clinics, and how collaborative research can advance the use of blood-based biomarkers in Alzheimer's diagnosis.